MY7500052A - Process for purifying cephaloglycin antibiotic thus obtained - Google Patents

Process for purifying cephaloglycin antibiotic thus obtained

Info

Publication number
MY7500052A
MY7500052A MY52/75A MY7500052A MY7500052A MY 7500052 A MY7500052 A MY 7500052A MY 52/75 A MY52/75 A MY 52/75A MY 7500052 A MY7500052 A MY 7500052A MY 7500052 A MY7500052 A MY 7500052A
Authority
MY
Malaysia
Prior art keywords
cephaloglycin
antibiotic
purifying
purifying cephaloglycin
cephaloglycin antibiotic
Prior art date
Application number
MY52/75A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MY7500052A publication Critical patent/MY7500052A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
MY52/75A 1969-02-17 1975-12-30 Process for purifying cephaloglycin antibiotic thus obtained MY7500052A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79999169A 1969-02-17 1969-02-17

Publications (1)

Publication Number Publication Date
MY7500052A true MY7500052A (en) 1975-12-31

Family

ID=25177238

Family Applications (1)

Application Number Title Priority Date Filing Date
MY52/75A MY7500052A (en) 1969-02-17 1975-12-30 Process for purifying cephaloglycin antibiotic thus obtained

Country Status (17)

Country Link
US (1) US3496171A (fr)
AT (1) AT293618B (fr)
BE (1) BE742086A (fr)
BR (1) BR6914264D0 (fr)
CH (1) CH531006A (fr)
CS (1) CS157076B2 (fr)
CY (1) CY784A (fr)
DE (1) DE1958329C3 (fr)
ES (1) ES373868A1 (fr)
FR (1) FR2031460B1 (fr)
GB (1) GB1254148A (fr)
IE (1) IE33619B1 (fr)
IL (1) IL33326A (fr)
MY (1) MY7500052A (fr)
NL (1) NL6917696A (fr)
PL (1) PL83176B1 (fr)
SE (1) SE372536B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
WO2011139254A2 (fr) * 2010-05-04 2011-11-10 Mahmut Bilgic Formulations pharmaceutiques comprenant du céfuroxime axétil

Also Published As

Publication number Publication date
IE33619L (en) 1970-08-17
ES373868A1 (es) 1972-02-16
NL6917696A (fr) 1970-08-19
BR6914264D0 (pt) 1973-02-22
PL83176B1 (fr) 1975-12-31
IL33326A0 (en) 1970-01-29
CS157076B2 (fr) 1974-08-23
FR2031460A1 (fr) 1970-11-20
DE1958329C3 (de) 1974-05-02
US3496171A (en) 1970-02-17
CH531006A (fr) 1972-11-30
DE1958329A1 (de) 1970-10-22
CY784A (en) 1976-06-01
FR2031460B1 (fr) 1973-04-06
AT293618B (de) 1971-10-25
IE33619B1 (en) 1974-09-04
DE1958329B2 (de) 1973-09-27
IL33326A (en) 1973-02-28
BE742086A (fr) 1970-05-25
SE372536B (fr) 1974-12-23
GB1254148A (en) 1971-11-17

Similar Documents

Publication Publication Date Title
YU294570A (en) Process for preparing delta-alkylamino-propiophenones
YU198170A (en) Process for preparing novel beta-aryl-2-aminoalkoxy-styrenes
YU254475A (en) Process for preparing novel 1-phenoxy-2-hydroxy-3-cycloalkyl-aminopropanes
CA930554A (en) Purification process
YU35868B (en) Process for preparing naphthylalkylamines
ZA703207B (en) Antibiotic compounds and process for preparing the same
YU27870A (en) Process for preparing novel antibiotics
YU33975B (en) Process for preparing bufatrienolide-rhamnoside-acylates
MY7500052A (en) Process for purifying cephaloglycin antibiotic thus obtained
CA930958A (en) Purification process
YU34399B (en) Process for preparing thiamphenicol-glycinate acetylcysteinate
CA821610A (en) Process for purifying polyolefins
CA927611A (en) Purification process
CA919921A (en) Purification process
YU188170A (en) Process for preparing 5-hydroxy-or 6-hydroxy-isoquinuclidines
CA933756A (en) Purification process
YU34788B (en) Process for preparing 3-chloro-4-n-and-iso-propoxy-ureas
YU201270A (en) Process for preparing phenyl-3-tert.-butyl-5-oxadiazolone-2
AU438401B2 (en) Process for purifying chlorosilanes
KR780000173B1 (en) Process for producting -aryl-2aminoalkoxy-styrole
KR780000171B1 (en) Process for producting-aryl-2aminoalkoxy-styrole
CA836090A (en) Process for purifying polyolefins
CA806230A (en) Process for synthesizing urea
CA829911A (en) Purification process
AU438512B2 (en) Purification process